Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
The latest announcement is out from Vireo Growth ( (TSE:VREO) ).
Vireo Growth Inc., a medical cannabis operator with a national portfolio strategy and strong local market focus, is expanding its platform through targeted investments in leadership and assets. The company seeks to leverage its disciplined approach and long-term mindset to strengthen its positioning across the cannabis value chain.
Vireo announced an update on its nonbinding agreement to acquire The Hawthorne Gardening Company from ScottsMiracle-Gro in a share-based transaction that could close as early as five business days after this announcement, subject to definitive agreements and regulatory approvals. The planned deal would transfer Hawthorne’s indoor and hydroponic gardening business, along with cash, net working capital, and inventory, to Vireo in exchange for newly issued shares and warrants, and includes the proposed appointment of Hawthorne’s executive lead Chris Hagedorn to Vireo’s board, potentially reshaping Vireo’s scale and capabilities in cultivation-related inputs.
More about Vireo Growth
Vireo Growth Inc. is a U.S.-based medical cannabis company founded in 2014 that is building a disciplined, execution-focused platform in the cannabis industry. The company emphasizes a strong local market focus while leveraging a national portfolio, investing capital and talent where it sees the highest value, and positioning itself as a long-term operator committed to customers, employees, shareholders, partners, and communities.
YTD Price Performance: -38.55%
Average Trading Volume: 43,264
Technical Sentiment Signal: Strong Sell
Current Market Cap: C$551M
For a thorough assessment of VREO stock, go to TipRanks’ Stock Analysis page.